Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bsu.edu.ru/handle/123456789/29278
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYakushev, V. I.-
dc.contributor.authorFilippenko, N. G.-
dc.contributor.authorKizilova, I. V.-
dc.contributor.authorKorokin, M. V.-
dc.contributor.authorBeskhmelnitsyna, E. A.-
dc.date.accessioned2020-04-10T12:52:33Z-
dc.date.available2020-04-10T12:52:33Z-
dc.date.issued2016-
dc.identifier.citationStudying dose-dependent endothelio- and cardioprotective activity of selective arginase II inhibitor in hyperhomocysteineinduced endothelial dysfunction / V.I. Yakushev [et al.] // Research Result: Pharmacology and Clinical Pharmacology. - 2016. - Vol.2, №1(2).-P. 42-45. - Doi: 10.18413/2313-8971-2016-2-1-42-45. - Refer.: p. 44-45.ru
dc.identifier.urihttp://dspace.bsu.edu.ru/handle/123456789/29278-
dc.description.abstractThis paper deals with the study of endothelio- and cardioprotective activity ofarginase II selective inhibitor, the substance under the code ZB49-0010C in the model of hyperhomocysteine-induced endothelial dysfunctionru
dc.language.isoenru
dc.subjectmedicineru
dc.subjectpharmacologyru
dc.subjectendothelial dysfunctionru
dc.subjecta selective inhibitorru
dc.subjectarginase IIru
dc.subjectnitric oxideru
dc.subjectmethionineru
dc.subjecthomocysteineru
dc.titleStudying dose-dependent endothelio- and cardioprotective activity of selective arginase II inhibitor in hyperhomocysteineinduced endothelial dysfunctionru
dc.typeArticleru
Appears in Collections:Research Result. Pharmacology and Clinical Pharmacology

Files in This Item:
File Description SizeFormat 
Yakushev_Studying.pdf493.57 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.